drugset / Trial / NCT01420328
To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects
RandomizedParallel-groupTriple-blindBasic science
Summary
This study focuses on the use of Vytorin to study inflammatory markers in subjects with normal cholesterol.
Timeline
- Start
- 2011-05-01
- Primary completion
- 2015-07-01
- Completion
- 2016-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ezetimibe | Unknown | 10 mg | — |
| Comparator | Simvastatin | Small molecule | 40 mg | — |
Indications
No indication recorded.